La importancia de los auto- anticuerpos IGG específicos tipo II en la enfermedad de MENIERE y pérdida progresiva de la audición
DOI:
https://doi.org/10.31053/1853.0605.v56.n2.40240Keywords:
Specific IgG to collagen II, autoimmunity, Progressive hearing loss, MeniereAbstract
The Meniere's Disease and Progressive Hearing Loss were considered idiopathic. Both entities were produced by endo lymphatic hydrops and disruption of the membrane which contain type II collagen. The inner ear presented widely expression of type II collagen. These pathologies were probably autoimmune diseases.
The aim of this work was to study the relationship of specific IgO to type II collagen in Meniere's disease, Progressive hearing loss, and compared with Sudden hearing loss patients, vascular vertigo patients and normal controls. Patients were divided by clinical findings in: 1° Meniere's disease (n:27), 2° Progressive Hearing loss (n:20), 3° Sudden hearing loss (n: 15), 4° Vascular Vertigo (n:9) and compared with normal controls (n:30) aged and sex matched. Wc have measured specific IgG to type II collagen by ELISA test. We considered positive the OD two or more SD aboye the mean of normal controis. Results: 1° The Meniere's group presented IgG to type II collagen (+) in'.)'.) out of 27 patients, p<.025; 20 The Progressive Hearing loss presented 1gG to type II collagen in alt cases (n:20), p<.0005. The Sudden Hearing loss presented 1gG to type II collagen
(-) in alt cases (n:15) p<.00001 and Vascular Vertigo (n:9) presented IgG to type II collagen (-) in 8 out of 9 cases, p<,0005. These results suggest strongly the notion that Meniere's diseases and Progressive hearing loss have specific IgG to type II collagen and these conditions were ascribed with in autoimmune process.
Downloads
References
Walton JM, Neurología , audición y vértigo en Fisiopatología, principios biológicos de la enfermedad. Smith y Thier editores. Panamericana, Buenos Aires, 1983; pp 1101-8.
Goodhill V. Sordera y Vértigo en el "Oído y sus Enfermedades" Salvat Barcelona 1986, pp 537- 61 Derebery MJ . The diagnosis and treatment of dizziness. Med Clin North Am. 1999; 89: 163-77.
Shea Ji. Classification of Meniére Disease. Am. J Oto] .1993; 14: 224-9
Krause HF Diagnostic patterns of Otolaryngic Allergy Symptons in Otolaryngic Allergy and Immunology. Saunders, Philadelphia, 1989; pp 51-2 Macabe BF. Autoimmnue sensorineural hearing loss.Ann Otol Rhinol Layngo1.1979;88: 585-9
Yoshimo K, Ohashi T, Urushibata T, Kenmochi M, Akagi M. Antibodies lo type II collagen and immunc complexes in Meniére Disease. Acta Otolaryngol (Stockh) 1996, suppl 552: 79-85.
Quor p K, Rostgaard J. Hoistein - Rathlou NH, Bretlou P. The endolymphatic sae, a potential endocrine gland. Acta Otollaryngol. 1999; 119:194-9.
Lodish H, Baltimore D, Berk A, Zipursky SL, Matsudoira P, Darnel J. Collagen: A class of multifunctional Fibrous Proteins, in Molecular CelI Biology 3erd edition. Scientific American Books; New York, 1996,pp 1126-42.
Albert B, Bray JC, Lewis J, Raff M, Roberts K. Watson JD. The extracellular rnatrix in Molecular Biology of the Cell 3erd edition.
Garland Publishers Inc. New York. 1994; pp 971- 95.
Yoo TJ, Stuart JM, Kang AH, Townes AS, Tomoda T, Dixit S, Type II collagen autoimmunity in otosclerosis and Meniere's Disease. Science 1982; 217: 1153-5
Zinkernagel RM, Kelly J. How antigen influences Immunity. The Immunologist.1997; 5: 114-20.
Kumar y, Seicarz E, Adorini L Regulatory Mechanisms lo Organ - Specific Autoimmunity. The Immunologist. 1998;6 :161 -6.
Pearson BW, Brackman DE, Committe on Hearing and Equilibrium guide]ines for Reporting treatment results in Meniere
disease. Otolaryngol Head Neck Surg, 1985; 93: 579-81
Weber PC, Klein AJ. Hearing loss. Med Clin North Am. 199933: 125 -37.
Trentham DE, Dynesius - Trentham RA, Orav EJ, Combitchi D, Lorenzo C, Sewel KL, Haffer DA . Weiner HL. Effect of oral
administration of Type II collagen on rheumatoid arthritis . Science , 1993; 259 1321 -4.
Nieto A, Carbonetto CH, Enzimoinmunoensayo (ELISA) en Inmunología e Inmunoquímica. Margni editor. Panamericana , Buenos Aires, 1989. Pp 571- 86.
Fujii K, Tsuji M, Murota K, Teroto K, Shimozuru Y, Nagai Y. An improved enzyme - ]inked immunosorbent assay of
anticollagen antibodies in human serum. J Imniunol Meth. 1989; 124 : 63 -70.
Arnold W, Pfaltz R, Altermatt HJ. Evidence of serum antibodies against inner ear tissue in the blood of patients with certain sensorineural hearing disorders. Acta Otolarygol (Stockh) 1985; 99: 437-44.
Vaughan JH. Enfermedades auto - alérgicas y consideraciones generales. Enfermedades Inmunológicas Max Samter editor. Toray,
Barcelona 1984, pp 1065 -72.
Tomoda K, Yamashita T, Kumazawa T, YooTJ, Type II collagen distribution in niiddle and iner ear immunohistochemical studies. Ear Res Jpn 1984; 15: 199-202.
Yoo TJ, Yazawa Y, Tomoda K, Floyd R. Type II collagen - induced autoimmune endolymphatyc hydrops in ginea pigs. Science 1983; 222: 65-7.
Yoo Ti, Tomoda K, Stuart JM, Type II collagen induced autoimni une sensorineural hearing loss and vestibular dysfunction in rats. Ann Oto] Rhinol Laryngol 1983; 92: 267-71.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Universidad Nacional de Córdoba
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The Faculty of Medical Sciences Journal (RFCM) subscribes to the Open Access policy and does not charge authors fees for publishing, nor does it charge readers fees for accessing published articles (APC).
